Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RARα chimeric gene: A retrospective study of clinical feasibility

Tohoku Journal of Experimental Medicine

Volumn 193, Issue 2, 2001, Pages 127-139

  Suzuki, Hoshiro ^f   Imaizumi, Masue ^a   Sato, Atsushi ^f   Yoshinari, Miyako ^f   Rikiishi, Takeshi ^f   Endo, Mikiya ^b   Takano, Toshikuni ^b   Shimizu, Toshiyuki ^c   Hatae, Yoshiro ^d   Fujimoto, Takeo ^e   Hayashi, Yutaka ^a   Iinuma, Kazuie ^f  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d HOKKAIDO CANCER CENTER   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; PRIMER DNA; RETINOIC ACID RECEPTOR;

ADOLESCENT; ALLELE; ARTICLE; BONE MARROW; CHILD; DNA SEQUENCE; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MALE; PATHOLOGY; PRESCHOOL CHILD; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ALLELES; BONE MARROW; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 0035257571     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.193.127     Document Type: Article

References (35)

1. Benedetti, L., Levin, A.A., Scicchitano, B.M., Grignani, F., Allenby, G., Diverio, D., Lo Coco, F., Avvisati, G., Ruthardt, M., Adamo, S., Pelicci, P.G. & Nervi, C. (1997) Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells. Blood, 90, 1175-1185.
2. Breitman, T.R., Selonick, S.E. & Collins, S.J. (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77, 2936-2940.
3. Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
4. Castaigne, S., Chomienne, C., Daniel, M.T., Ballerini, P., Berger, R., Fenaux, P. & Degos, L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76, 1704-1709.
5. Chen, Z.X., Xue, Y.Q., Zhang, R., Tao, R.F., Xia, X. M., Li, C., Wang, W., Zu, W.Y., Yao, X.Z. & Ling, B.J. (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood, 78, 1413-1419.
6. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
7. Diverio, D., Pandolfi, P.P., Rossi, V., Biondi, A., Pelicci, P.G. & Lo Coco, F. (1994) Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia, 8, 1105-1107.
8. Diverio, D., Rossi, V., Avvisati, G., De Santis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M.C., Santoro, A., Pelicci, P.G., Mandelli, F., Biondi, A. & Lo Coco, F.L. (1998) Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. Blood, 92, 784-789.
9. Fenaux, P., Chastang, C. & Degos, L. (1994) Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group. Leukemia, 8, S42-S47.
10. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Miyawaki, S., Shimazaki, C., Miyake, T., Nakayama, Y., Kobayashi, H., Goto, S., Takeshita, A., Kobayashi, S., Kato, Y., Shiraishi, K., Sasada, M., Ohtake, S., Murakami, H., Kobayashi, M., Endo, N., Shindo, H., Matsushita, K., Hasegawa, S., Tsuji, K., Ueda, Y., Tominaga, N., Furuya, H., Inoue, Y., Takeuchi, J., Morishita, H., Iida, H. & the Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) (1995) Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. Leukemia, 9, 1478-1482.
11. Grimwade, D., Howe, K., Langabeer, S., Burnett, A., Goldstone, A. & Solomon, E. (1996) Minimal residual disease detection in acute promyelocytic leukemia by reversetranscriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse. Leukemia, 10, 61-66.
12. Guglielmi, C., Martelli, M.P., Diverio, D., Fenu, S., Vegna, M.L., Cantu-Rajnoldi, A., Biondi, A., Cocito, M.G., Del Vecchio, L., Tabilio, A., Avvisati, G., Basso, G. & Lo Coco, F. (1998) Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br. J. Haematol., 102, 1035-1041.
13. Hirota, T., Fujimoto, T., Katano, N., Tsurusawa, M., Eguchi, H., Nakadate, N., Kamitamari, A., Kawakami, K., Nishikawa, K., Asami, K., Shirahata, A., Koizumi, S., Mugishima, H., Gushiken, T., Hyakuna, N., Imaizumi, M., Komatu, K., Takitani, K., Miyake, M. & Yanase, T. (1997) II Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Jpn. J. Clin. Hematol, 38, 1177-1182. (in Japanese with English abstract)
14. Hirota, T., Fujimoto, T., Katano, N., Tsurusawa, M., Hatae, Y., Kamitamari, A., Nishikawa, K., Asami, K., Yanase, T., Koizumi, S., Mugishima, H., Hyakuna, N., Imaizumi, M., Watanabe, A., Takitani, K. & Miyake, M. (1999) Treatment results of CCLSG APL-ATRA protocol in childrenhood acute promuelocytic leukemia (abstract). Jpn. J. Clin. Hematol., 40, 1006. (in Japanese)
15. Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. & Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
16. Imaizumi, M. & Breitman, T.R. (1987) Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia. Eur. J. Haematol., 38, 289-302.
17. α portion of the PML/RARo-chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood, 92, 374-382.
18. Jurlander, J., Caligiuri, M.A., Ruutu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., Hoffmann, L., Ball, E.D., Frei-Lahr, D.A., Christiansen, N.P., Block, A.M., Knuutila, S., Herzig, G.P. & Bloomfield, C.D. (1996) Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8; 21) leukemia. Blood, 88, 2183-2191.
19. Kigasawa, H., Akiyama, Y., Ohira, M., Tukimoto, I. & Nagao, T. (1998) Prospective comparison between postinduction chemotherapy and various types of stem-cell transplantations for childhood acute myeloid leukemia using Japan Cooperative Protocol ANLL91 (abstract). Med. Pediatr. Oncol, 31, 225.
20. Laczika, K., Mitterbauer, G., Korninger, L., Knobl, P., Schwarzinger, I., Kapiotis, S., Haas, O.A., Kyrle, P.A., Pont, J., Oehler, L. Purscher, B., Thalhammer, F., Lechner, K. & Jaeger, U. (1994) Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. Leukemia, 8, 1-5.
21. Lo Coco, F., Nervi, C., Avvisati, G. & Mandelli, F. (1998) Acute promyelocytic leukemia: a curable disease. Leukemia, 12, 1866-1880.
22. Lo Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G. & Mandelli, F. (1999) Therapy of molecular relapse in acute promyelocytic leikemia. Blood, 94, 2225-2229.
23. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo Coco, F. (1997) Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 90, 1014-1021.
24. Mensink, E., van de Locht, A., Schattenberg, A., Linders, E., Schaap, N., Geurts van Kessel, A. & De Witte, T. (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br. J. Haematol, 102, 768-774.
25. Miller, W.H., Jr., Levine, K., DeBlasio, A., Frankel, S.R., Dmitrovsky, E. & Warrell, R.P., Jr. (1993) Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. Blood, 82, 1689-1694.
26. Miyamura, K., Tanimoto, M., Morishima, Y., Horibe, K., Yamamoto, K., Akatsuka, M., Kodera, Y., Kojima, S., Matsuyama, K., Hirabayashi, N., Yazaki, M., Imai, K., Onozawa, Y., Kanamaru, A., Mizutani, S. & Saito, H. (1992) Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood, 79, 1366-1370.
27. Radich, J., Gehly, G., Lee, A., Avery, R., Bryant, E., Edmands, S., Gooley, T., Kessler, P., Kirk, J., Ladne, P., Thomas, E.D. & Appelbaum, F.R. (1997) Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood, 89, 2602-2609.
28. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. & Erlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487-491.
29. Sanger, F., Nicklen, S. & Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
30. Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., Ohki, M. & Kaneko, Y. (1995) Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8; 21) in long-term remission. Br. J. Haematol., 91, 892-898.
31. Tobal, K. & Liu Yin, J.A. (1998) RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL. Leukemia, 12, 1349-1354.
32. Uzuka, Y., Liong, S. K. & Yamagata, S. (1976) Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy. Tohoku J. Exp. Med., 118, 217-225.
33. Vahdat, L., Maslak, P., Miller, W.H., Jr., Eardley, A., Heller, G., Scheinberg, D.A. & Warrell, R.P., Jr. (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood, 84, 3843-3849.
34. Warrell, R.P., Jr., Frankel, S.R., Miller, W.H., Jr., Scheinberg, D.A., Itri, L.M., Hittelman, W.N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M.S. & Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med., 324, 1385-1393.
35. Warrell, R.P., Jr. (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood, 82, 1949-1953.